Last Week’s Hot Topic on Cystic Fibrosis

admin avatar

by admin |

Share this article:

Share article via email



Last week’s hot topic on Cystic Fibrosis titled Potential Cystic Fibrosis Therapy Gets FDA Fast Track Approval, Clinical Tests to Follow was written by Carolina Henriques.

The article is focused on the announcement by Proteostasis Therapeutics, Inc., that it recently received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for PTI-428, an investigational oral treatment for cystic fibrosis (CF).

PTI-428 is an oral modulator in the amplifier class. The designation may make the drug eligible for priority review later on.

Read more articles about cystic fibrosis here:

Featured Column

What It’s Like to Have a Family Member in the ICU

Main graphic for "Safe and Sound," Cystic Fibrosis News Today, by columnist Shelby Dell
Five years after her brother, Bradley, fought for his life in the ICU, columnist Shelby Dell reflects on how his hospitalization affected her.

Read the Column

Your CF Community

Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.